+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Encephalitis Drug"

Encephalitis Treatment Global Market Report 2024 - Product Thumbnail Image

Encephalitis Treatment Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
Autoimmune Encephalitis (AE) - Pipeline Insight, 2024 - Product Thumbnail Image

Autoimmune Encephalitis (AE) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
Tick Borne Encephalitis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Tick Borne Encephalitis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Japanese Encephalitis - Pipeline Review, H2 2020 - Product Thumbnail Image

Japanese Encephalitis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 46 Pages
  • Global
From
Encephalitis - Pipeline Review, H2 2019 - Product Thumbnail Image

Encephalitis - Pipeline Review, H2 2019

  • Drug Pipelines
  • August 2019
  • 47 Pages
  • Global
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Encephalitis is an inflammation of the brain caused by a virus or other infectious agent. Infectious Diseases Drugs are used to treat this condition, and the Encephalitis Drug market is a subset of this larger market. These drugs are used to reduce inflammation, reduce symptoms, and prevent further damage to the brain. They may also be used to treat complications such as seizures, coma, and death. Common drugs used to treat encephalitis include antivirals, corticosteroids, and immunosuppressants. The Encephalitis Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in this market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Johnson & Johnson. Other companies include AstraZeneca, Novartis, and Bristol-Myers Squibb. Show Less Read more